Revised SPCs: Gilenya (fingolimod hydrochloride) hard capsules – all strengths
SPCs revised to include acute hepatic failure as an adverse effect of treatment of unknown frequency.
Source:
electronic Medicines compendium
SPCs revised to include acute hepatic failure as an adverse effect of treatment of unknown frequency.
electronic Medicines compendium